Vida Pharmacal develops, markets, and distributes pharmaceuticals designed to treat Neglected Tropical Diseases (NTDs) for human and veterinary patients. Founded in 2017, the company has developed the world’s first treatment for Chagas disease in canines. Vida Pharmacal is headquartered in Spring Branch, Texas and is privately held.
The Story Behind Vida Pharmacal
Until recently, Chagas disease was almost unknown in the U.S. From an unwanted shelter dog with the disease to a human patient in Venezuela, God brought together a Texas veterinarian and a Venezuelan physician. The story of Vida Pharmacal and its drug development process is as amazing as the treatment itself.